Aptevo Therapeutics (APVO) Tax Provisions (2016 - 2019)
Historic Tax Provisions for Aptevo Therapeutics (APVO) over the last 4 years, with Q3 2019 value amounting to -$999000.0.
- Aptevo Therapeutics' Tax Provisions changed N/A to -$999000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was -$23.5 million, marking a year-over-year change of. This contributed to the annual value of -$23.3 million for FY2017, which is 1832.72% down from last year.
- As of Q3 2019, Aptevo Therapeutics' Tax Provisions stood at -$999000.0.
- In the past 5 years, Aptevo Therapeutics' Tax Provisions registered a high of -$11000.0 during Q2 2016, and its lowest value of -$17.6 million during Q3 2016.
- Over the past 4 years, Aptevo Therapeutics' median Tax Provisions value was -$909500.0 (recorded in 2017), while the average stood at -$3.7 million.
- In the last 5 years, Aptevo Therapeutics' Tax Provisions skyrocketed by 9820.26% in 2016 and then plummeted by 895454.55% in 2017.
- Over the past 4 years, Aptevo Therapeutics' Tax Provisions (Quarter) stood at -$610000.0 in 2015, then tumbled by 80.66% to -$1.1 million in 2016, then plummeted by 600.0% to -$7.7 million in 2017, then surged by 87.05% to -$999000.0 in 2019.
- Its last three reported values are -$999000.0 in Q3 2019, -$7.7 million for Q4 2017, and -$13.8 million during Q3 2017.